about
Iosimenol, a low-viscosity nonionic dimer: preclinical physicochemistry, pharmacology, and pharmacokinetics.Preclinical evaluation of radiolabelled nimotuzumab, a promising monoclonal antibody targeting the epidermal growth factor receptor.Preclinical evaluation of gastrin derivatives labelled with 111In: radiolabelling, affinity profile and pharmacokinetics in rats.The effect of chelator type on in vitro receptor binding and stability in 177Lu-labeled cetuximab and panitumumab.A comparison of in vitro methods for determining the membrane receptor expression in cell lines.Protein interactions with HER-family receptors can have different characteristics depending on the hosting cell line.Preparation and the kinetic stability of hyaluronan radiolabeled with 111In, 125I and 14C.Influence of P-glycoprotein on the transplacental passage of cyclosporine.Complexation and biodistribution study of 111In and 90Y complexes of bifunctional phosphinic acid analogs of H4dota.Analysis of accumulation of 99mTc-octreotide and 99mTc-EDDA/HYNIC-Tyr3-octreotide in the rat kidneys.In vitro comparison of renal handling and uptake of two somatostatin receptor-specific peptides labeled with indium-111.Mono(pyridine-N-oxide) DOTA analog and its G1/G4-PAMAM dendrimer conjugates labeled with 177Lu: radiolabeling and biodistribution studies.The involvement of selected membrane transport mechanisms in the cellular uptake of (177)Lu-labeled bombesin, somatostatin and gastrin analogues.Effect of plasma binding of ortho- and para-I-benzoates on their distribution in blood and into lymph, biotransformation and excretion in rat urineInterspecies pharmacokinetic scaling of some iodinated organic acidsProtein binding of tolfenamic acid in the plasma from patients with renal and hepatic diseasePlasma protein binding-lipophilicity relationships: interspecies comparison of some organic acidso- and M-iodohippurate binding to plasma proteins as a model drug transport mechanismPharmacokinetics and distribution of ribonuclease and its monomethoxypoly(ethylene glycol) derivatives in ratsComparison of biological characteristics of EDTMP complexes with 99mTc, 111In and 153Sm in ratsKidney and liver contributions to salicylate metabolism in ratsRenal handling of iodobenzoates in ratsHPLC-radiometric determination of quinlukast in biological fluids99mTc demotate 1: biodistribution and elimination characteristics in ratsPharmacokinetics of radiolabelled quinlukast in ratsDistribution, elimination, and renal handling of (99m)technetium-Demogastrin 1Radiolabeling of PAMAM dendrimers conjugated to a pyridine-N-oxide DOTA analog with ¹¹¹In: Optimization of reaction conditions and biodistributionElectrospinning of diosmin from aqueous solutions for improved dissolution and oral absorptionPharmacokinetics and distribution of 125I-PLA-b-PEO block copolymers in rats
P50
Q34547019-554E5CFC-1633-4416-808F-D4B06EAF1FEEQ39052926-B3C12BD1-9301-404F-9244-76BAB66E7ECDQ39084069-4CDC50C2-7545-4996-96D7-4FEA3AE1D995Q39182026-95067625-B014-40B8-9645-64B30CCA4B09Q39365287-DEAC422B-DCC4-4D35-B053-F085581BCBD8Q39421909-4218E422-1AE7-4A49-B16E-A34192049965Q43147309-4DE49A2D-6F1B-442D-9894-B8D2FF6A650FQ43824716-98ABDAA4-4765-483C-836A-63A22E6B8AF6Q44369751-AEE104DC-F618-4974-B3FD-462CB7E879A6Q44794920-E6A7231C-3016-47A1-9192-B512CD729CA6Q46163990-E41C639D-3509-443A-BAA9-2F257C5CF99EQ46960181-7E3E2C3C-AA67-4218-8E3E-4DABA1FAB016Q53771666-D5101E87-EE9F-45C8-8490-1F433100C745Q60526138-35DA6D71-3436-4F4D-9F2A-019CE5ED5DF3Q68165183-FFB1C9EE-AED4-4767-A773-861FE5BF535CQ69617300-F1763B6C-BE1B-4961-A2B2-D5211E39D152Q69896286-38FEAE80-E434-46BB-BC32-419E21A763B2Q72592943-537D30B3-350D-411C-ACAA-06D6A3AE045EQ72698583-02AEF824-0FE4-479A-AEF3-DDD3A6800E03Q72781543-5D3DDAC0-96DA-44FC-8D3F-C0CD3FC70417Q72797588-9C7CD2C3-5EF5-48CC-9802-373837C2438CQ73100788-C700D4F2-533A-407A-A638-2ED0E7005AA9Q79798030-B6E0ED5B-A840-4597-B3ED-5A57FD532FF6Q81743768-AECBBB53-65E7-4979-AD1C-AF8C7E2CD089Q81798526-75291D4D-F9EE-4587-AE6E-8CCF1CEBC18BQ83625660-9EF4AF17-76AB-4422-B9DF-F27A79480DA1Q84561199-DF989A60-CE35-44BE-8B3F-0906D087F63AQ87451346-36980F71-05B2-4E30-940E-D8BE12EF7B9AQ94191669-17805FF5-0F56-45B6-B689-0DDB172C96CE
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
M Láznícek
@ast
M Láznícek
@en
M Láznícek
@es
M Láznícek
@nl
type
label
M Láznícek
@ast
M Láznícek
@en
M Láznícek
@es
M Láznícek
@nl
prefLabel
M Láznícek
@ast
M Láznícek
@en
M Láznícek
@es
M Láznícek
@nl
P31
P496
0000-0001-7360-8939